List view / Grid view




Chronos Therapeutics appoints new VPs for MS and PTSD research

4 August 2016 | By Niamh Marriott, Digital Content Producer

Chronos Therapeutics, a biotech company researching ageing diseases, brain and nervous system disorders, have announced the appointment of Dr Fraser Murray and Dr Timothy Schulz-Utermoehl, as Vice Presidents of Pre-Clinical Development...


MSD acquires drug discovery company IOmet

12 January 2016 | By Victoria White

The acquisition includes IOmet's comprehensive preclinical pipeline of IDO (indoleamine-2,3-dioxygenase 1), TDO (tryptophan-2,3-dioxygenase), and dual-acting IDO/TDO inhibitors...